Search

Search Constraints

You searched for: Author/Creator Mesa, Ruben

Search Results

23. Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study. Issue 3 (March 2020)

25. Momelotinib reduces transfusion requirements in patients with myelofibrosis. Issue 7 (7th June 2022)

26. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study. Issue 10373 (28th January 2023)

27. Myeloproliferative neoplasm patient symptom burden and quality of life: Evidence of significant impairment compared to controls. Issue 10 (10th September 2015)

28. Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey. Issue 1 (December 2016)

29. Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey. Issue 1 (December 2016)

30. Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey. Issue 1 (December 2016)